Thermo Fisher Scientific Inc. (TMO) operating KPIs
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$697.00−12.18 (-1.72%)
Close on Oct 30, 2026Market cap $257.71BP/E 36.8Yield 0.25%
Thermo Fisher Scientific tổng số báo cáo biến cố thiết bị MAUDE toàn ngành tại Hoa Kỳ (U.S. Industry Total MDRs)
U.S. FDA openFDA MAUDE Adverse Event API
Latest, Q3 2026
1,189,467
Period ended Sep 30, 2026
Change on a year earlier
+45.2%
819,444 in Q3 2025
History
43 quarters
Since Q1 2016
Sources
1
openFDA MAUDE Adverse Event Reports — U.S. Device Industry Total
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Thermo Fisher Scientific Tổng số báo cáo biến cố thiết bị MAUDE toàn ngành tại Hoa Kỳ (U.S. Industry Total MDRs), quarterly Q1 2016–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/fda_maude_industry
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.